DaVita Inc. Profile Avatar - Palmy Investing

DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatie…

Medical - Care Facilities
US, Denver [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
All monetary values are presented in USD ($). E stands for Estimate.
2014 3.0200 3.300 11,764 12,007 633 673 2,026 2,021 1,458 1,690 1,176 1,177
2015 3.4100 3.771 12,795 13,756 723 263 2,310 1,577 1,791 1,144 1,261 1,424
2016 1.2700 3.781 13,781 14,764 269 847 1,979 2,352 1,362 1,795 1,452 1,395
2017 4.3600 3.439 14,745 15,411 879 653 2,515 2,029 1,773 1,225 1,592 1,506
2018 3.5200 3.623 10,876 11,541 663 65 2,406 1,446 1,619 1,539 1,064 1,199
2019 4.6300 5.262 11,404 11,410 790 724 2,086 1,921 1,490 1,460 1,135 978
2020 5.2900 7.454 11,388 11,572 810 603 2,412 1,582 1,755 1,327 1,103 982
2021 6.5400 8.886 11,550 11,586 773 838 2,358 1,934 1,683 1,546 1,247 1,030
2022 9.3000 6.207 11,618 11,624 978 839 2,484 2,105 1,770 1,647 1,195 1,237
2023 8.2600 7.977 11,609 12,006 768 691 2,055 2,397 1,312 1,876 1,355 1,408
2024 7.6200 9.706 12,140 12,760 691 904 2,346 2,552 1,601 1,808 1,473 1,393
2025 - 11.328 - 13,213 - 1,061 - 2,643 - 1,872 - 1,442
2026 - 13.629 - 13,692 - 2.F12X/td> - 2.F121/td> - 2.F121 - 2.F121
2027 - 15.837 - 14,254 - 1.F13X/td> - 1.F131/td> - 1.F131 - 1.F131
2028 - 18.203 - 14,752 - 0.F14X/td> - 0.F141/td> - 0.F141 - 0.F141
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
Price Target Consensus

-5.624% $8.54 · MISS

Nov. 6, 2024
Price Then
$147.08
Price Target
$160.39
Price Now
$151.85
End of DVA's Analysis
CIK: 927066 CUSIP: 23918K108 ISIN: US23918K1088 LEI: - UEI: -
Secondary Listings